What can we do for you?
Navigating the regulatory landscape can indeed be challenging, especially when developing groundbreaking therapies. These treatments have the potential to significantly enhance the lives of patients facing limited options. However, the path to approval and market access involves navigating a complex maze of regulatory requirements.
The FDA and EMA provide several expedited approval pathways aimed at accelerating the availability of innovative medical treatments. Notable examples of these pathways include:
- Fast Track Designation: Expedites development and review processes for therapies addressing serious conditions with unmet medical needs.
- Breakthrough Therapy Designation: Facilitates accelerated development and review of treatments demonstrating substantial improvement over existing therapies.
- Accelerated Approval: Permits approval based on surrogate endpoints that are likely to predict clinical benefit.
- Priority Review: Aims to complete review within 6 months for therapies addressing significant health issues.
- Regenerative Medicine Advanced Therapy (RMAT) Designation: Supports development of regenerative medicine products intended for serious conditions.
- Conditional Marketing Authorisation: Grants provisional approval based on a positive benefit-risk assessment, allowing access to therapies addressing unmet medical needs.
- PRIME (PRIority MEdicines) Scheme: Accelerates assessment and approval timelines for medicines with significant therapeutic innovation potential.
- Committee for Advanced Therapies (CAT): Specialized committee evaluating the quality, safety, and efficacy of advanced therapies.
- Accelerated Assessment: Shortens the review period for medicines of major interest for public health, reducing time to market while maintaining rigorous evaluation standards.
These pathways are crucial in fostering innovation and swiftly bringing transformative therapies to patients in need.
Partnering with our regulatory consultancy ensures that you have expert guidance and support to navigate the expedited approval pathways offered by the FDA and EMA.
Here's how we can support you ›
With our personalized approach, we’re committed to helping you navigate the complex regulatory landscape, streamline the approval process, and bring your innovative therapies to patients faster. Contact us to learn more about how we can support your success.
We'll carefully evaluate your therapeutic candidates to determine which expedited approval pathways you're eligible for, ensuring that your innovation meets all necessary criteria.
Our experts will provide personalized scientific advice to guide you through the development process. We'll help you prepare for and conduct pre-submission meetings with regulatory authorities, ensuring that your data and development plans are aligned with their expectations.
We will work closely with you to develop a tailored regulatory strategy. This involves identifying the most suitable expedited pathway for your product and crafting a plan that maximizes your chances of successful approval.
We will handle all communications with regulatory authorities on your behalf. From submitting inquiries to scheduling and preparing for meetings, and responding to requests for additional information, we ensure that every interaction is seamless and productive.
Our team will assist you in preparing and submitting high-quality regulatory dossiers. We ensure that all necessary documentation, data, and evidence are presented clearly and compliantly, giving you the best chance for approval.
We will oversee the entire regulatory process from start to finish. By coordinating timelines and managing milestones, we ensure that your project stays on track and meets all regulatory deadlines.
Our support does not end with approval. We will be there to assist with post-marketing surveillance, compliance monitoring, and any additional studies or reporting that may be required.
Approach & Expertise
Learn how we can support you in meeting your business goals
- Our lean and powerful team with degrees in pharmacy, chemistry, biology, or related studies strive to be of added value to you. Our short reporting lines enable the most efficient road to your success.
- Having one point of contact from our experts backed by the team’s collective knowledge and resources we give reliable advice and execute projects seamlessly.
- At Starodub, consistency and assurance of quality are vital. A quality management system has been implemented and we adhere to GxP and ISO 9001/13485.
Questions from our clients
FAQ Section
Accelerated approval designations can significantly shorten the time needed to bring your therapy to market. These designations are granted to treatments that address unmet medical needs or offer substantial improvements over existing therapies. By obtaining an accelerated approval designation, you can benefit from:
- Faster Review Times: Expedited evaluation by regulatory agencies.
- Increased Interaction: More frequent communications with regulatory authorities, allowing for early resolution of potential issues.
- Market Advantage: Earlier market entry compared to competitors, providing a significant commercial edge. Our team can help you identify the most suitable designation for your therapy and guide you through the application process to maximize these benefits.
The process of applying for an accelerated approval designation involves several critical steps:
- Pre-Submission Planning: Identifying the appropriate designation and preparing a strategic plan.
- Application Preparation: Compiling the necessary documentation and ensuring compliance with regulatory guidelines.
- Submission and Review: Submitting the application and managing interactions with regulatory authorities during the review process.
We offer specialized services at each stage of this process. Our expertise ensures that your application is robust, well-supported by data, and strategically presented to highlight the potential benefits of your therapy. We also manage ongoing communications with regulatory bodies, ensuring that any questions or concerns are promptly addressed to keep the review process on track.